LONDON (Alliance News) - Stock prices in London are called for a positive start on Friday, following Asian markets higher after progress was reported in talks between the US and China. IG futures Read More
LONDON (Alliance News) - Stock prices in London are seen opening in the green on Friday, with investors welcoming reports of progress between the US and China on trade.Meanwhile, has signed Read More
LONDON (Alliance News) - AstraZeneca PLC's lung cancer drug Imfinzi will be paid for by the UK National Health Service for use by eligible patients following approval by a UK regulator, it was Read More
LONDON (Alliance News) - FTSE 100-listed drug maker AstraZeneca PLC said Wednesday its blockbuster Forxiga drug had been approved by Japan for the treatment of diabetes alongside Japanese Ministry Read More
LONDON (Alliance News) - Stocks in London are set to open in positive territory on Wednesday, extending the previous session's gains as worries over the health of the global economy eased. In Read More
LONDON (Alliance News) - Stock prices in London are seen opening in the red on Monday, tracking Asian equity markets lower following heavy losses in the US on Friday, amid fears of an impending US Read More
LONDON (Alliance News) - AstraZeneca PLC on Monday said the first sub-analyses from its phase three trial of Farxiga found it reduced the relative risk of major adverse cardiovascular events in a Read More
LONDON (Alliance News) - Stock prices in London are seen opening in the green on Monday following strong gains in Asian equity markets overnight, amid hopes that a trade resolution between the US Read More
LONDON (Alliance News) - TI Fluid Systems PLC said Friday it hired former AstraZeneca PLC and Wincanton PLC executive Andrea Dunstan as a non-executive director at the liquid handling systems with Read More
LONDON (Alliance News) - AstraZeneca PLC on Friday said a committee of the European Medicines Agency has recommended cancer drug Lynparza for use in incurable breast cancer patients.The for Read More
LONDON (Alliance News) - FTSE 100-listed drugmaker AstraZeneca PLC and its partner Merck & Co Inc said Tuesday its potentially blockbuster Lynparza cancer treatment had met the primary of one Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------British up Read More
LONDON (Alliance News) - FTSE 100-listed drugmaker AstraZeneca PLC said Monday its late phase clinical trial for its blockbuster Brilinta cardiovascular drug had met its primary Phase III THEMIS - Read More
LONDON (Alliance News) - Stocks in London ended mixed on Thursday, with the FTSE 100 touching a fresh four-month high after strong gains from Micro Focus International and and in Read More
LONDON (Alliance News) - The FTSE 100 was posting its fourth consecutive session of gains on Thursday at midday as an overall improvement in market mood due to hopes for US-China trade talks got a Read More
LONDON (Alliance News) - AstraZeneca PLC on Thursday posted particularly strong annual sales growth from its Oncology segment, with lung cancer drug Tagrisso set to become its biggest seller in in Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Micro up Read More
LONDON (Alliance News) - The FTSE 100 was sustaining its recent winning streak in early trade on Thursday, boosted by well-received annual results from Micro Focus International a Read More
LONDON (Alliance News) - AstraZeneca PLC on Thursday posted a drop in annual profit after getting a boost from its Lynparza cancer drug collaboration the year before, though guided to earnings for Read More
LONDON (Alliance News) - London share prices are set to pull back slightly on Thursday following three consecutive sessions of gains which had been driven by hopes of a trade detente between the a Read More